Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Non-Current Deferred Tax Liability: 2011-2024

Historic Non-Current Deferred Tax Liability for Lifecore Biomedical (LFCR) over the last 14 years, with Nov 2024 value amounting to $552,000.

  • Lifecore Biomedical's Non-Current Deferred Tax Liability rose 32.69% to $552,000 in Q4 2024 from the same period last year, while for Nov 2024 it was $552,000, marking a year-over-year increase of 32.69%. This contributed to the annual value of $543,000 for FY2024, which is 96.19% down from last year.
  • Per Lifecore Biomedical's latest filing, its Non-Current Deferred Tax Liability stood at $552,000 for Q4 2024, which was up 24.60% from $443,000 recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical's Non-Current Deferred Tax Liability ranged from a high of $41.0 million in Q2 2020 and a low of $10,000 during Q4 2022.
  • Its 3-year average for Non-Current Deferred Tax Liability is $2.4 million, with a median of $499,500 in 2023.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first crashed by 99.17% in 2022, then surged by 4,060.00% in 2023.
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Non-Current Deferred Tax Liability stood at $6.6 million in 2020, then tumbled by 81.89% to $1.2 million in 2021, then plummeted by 99.17% to $10,000 in 2022, then soared by 4,060.00% to $416,000 in 2023, then spiked by 32.69% to $552,000 in 2024.
  • Its last three reported values are $552,000 in Q4 2024, $443,000 for Q3 2024, and $543,000 during Q2 2024.